Heart bypass surgery may be less dangerous for older patients with diabetes than angioplasty, researchers reported. Patients with diabetes were 30 percent less likely to die if they got the…
Read More »Abnormal Heart Rhythm Boosts Death Risk for Diabetics
Blood pressure and cholesterol need to be controlled more aggressively, a new study suggests.
Read More »Researchers Use Gene to End High Blood Sugars
Delivering a gene called neurogenin3 into the livers of diabetic mice activates adult stem cells that promote steady insulin production, say researchers.
Read More »Simple Tests May Predict Unseen Cardio Risk
Three simple clinical tests could help identify a large group of patients with elevated heart attack risk who aren’t reflected in traditional risk scores, researchers said.
Read More »Diabetic Patients with AF at Increased Risk of Adverse Events
Diabetic patients with atrial fibrillation (AF) are at a significantly greater risk of adverse clinical outcomes than those without AF, a new analysis has shown. Compared with those without the rhythm disorder, diabetic patients with AF are more likely to die from all or cardiovascular causes, as well as have …
Read More »Lowering Glucose in AMI Patients Improves Survival
Adding to evidence linking hyperglycemia and mortality in acute myocardial infarction (AMI) patients, a new observational study indicates that AMI patients with hyperglycemia at the time of hospital admission whose glucose levels fall to normal ranges during their hospital stay are more likely to survive.
Read More »Benefits of Coffee, Chocolate – The Results Are In!
The results are in and both coffee and chocolate have health benefits, but to what extent?
Read More »Two New Diabetes Drugs could be Approved by April 2nd
A U.S. Food and Drug Administration panel will review two proposed drugs to treat Type 2 diabetes this April. According to a meeting notice posted on the FDA’s website Monday, the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee will discuss Bristol-Myers Squibb’s saxagliptin tablets on April 1 and Novo Nordisk.’s liraglutide …
Read More »Oral Insulin “Oral-lyn” Phase III Study Shows Positive Results
Generex Biotechnology Corporation, a leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced positive results following the review of the Phase III data for the company’s flagship product, Generex Oral-lyn, a proprietary oral insulin spray product designed to replace prandial injections of insulin.
Read More »Cat-Naps Increase Diabetes Risk By 26%
Taking regular naps could increase the risk of diabetes, experts say. People who enjoy siestas often are 26% more likely to develop Type 2 diabetes, research has found.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.